NEW APPROACHES TO DONOR CROSSMATCHING AND SUCCESSFUL TRANSPLANTATION OF HIGHLY SENSITIZED PATIENTS1,2

Authors:
  • FDFrancis L. Delmonico
    Francis L. Delmonico
  • AFAnne Fuller
    Anne Fuller
  • BCBenedict A. Cosimi
    Benedict A. Cosimi
  • NTNina Tolkoff-Rubin
    Nina Tolkoff-Rubin
  • PRPaul S. Russell
    Paul S. Russell
  • GRGlenn E. Rodey
    Glenn E. Rodey
  • TFThomas C. Fuller
    Thomas C. Fuller
Publisher website
Google Scholar
Abstract
A class I HLA molecule may bear not only a private or unique determinant, but a shared, yet discrete, public epitope. These public determinants occur with a much higher frequency in the random donor population than the associated private determinants--and thus, are encountered more often in random donor blood transfusions and in renal transplantation. Sera from highly sensitized dialysis patients have been reported to contain a restricted number of antibodies to public determinants rather than a diverse array of antibodies directed against the private HLA-AB epitopes. As detailed in this report, comprehensive serum analysis of the public antibodies in highly sensitized transplant candidates has optimized identification of potential crossmatch-compatible donors and has avoided needless crossmatches. During the past two years, the incidence of renal transplantation from cadaveric donors to highly sensitized recipients has doubled at this institution. At 10-25 months following transplantation, 70% of these allografts are functioning. Private HLA class I antigen incompatibility was not a barometer for exclusion in the final donor crossmatch of these highly sensitized recipients. Furthermore, positive donor T cell crossmatches with sera obtained more than six months prior to transplantation may not represent an impediment to successful transplantation. We conclude that the approach of detailed antibody analysis can result in an improved outlook for successful transplantation of more dialysis patients who are highly sensitized to the class I HLA alloantigens.